These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27129086)

  • 1. Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations.
    Skoczylas A; Piecha G; Więcek A
    Pol Arch Med Wewn; 2016 Apr; 126(4):243-53. PubMed ID: 27129086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease.
    Nutahara K; Higashihara E; Horie S; Kamura K; Tsuchiya K; Mochizuki T; Hosoya T; Nakayama T; Yamamoto N; Higaki Y; Shimizu T
    Nephron Clin Pract; 2005; 99(1):c18-23. PubMed ID: 15637459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
    Yamashita T; Inoue H; Okumura K; Kodama I; Aizawa Y; Atarashi H; Ohe T; Ohtsu H; Kato T; Kamakura S; Kumagai K; Kurachi Y; Koretsune Y; Saikawa T; Sakurai M; Sato T; Sugi K; Nakaya H; Hirai M; Hirayama A; Fukatani M; Mitamura H; Yamazaki T; Watanabe E; Ogawa S;
    Europace; 2011 Apr; 13(4):473-9. PubMed ID: 21148662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria.
    Okura T; Kojima M; Machida H; Sugiyama M; Kato T; Komada T; Miyazaki T; Ninomiya T; Ichikawa T; Nakatani K; Watanabe Y; Dohi Y; Ito M; Kimura G
    J Hum Hypertens; 2012 Apr; 26(4):214-9. PubMed ID: 21412266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.
    Agnoletti D; Zhang Y; Borghi C; Blacher J; Safar ME
    Am J Hypertens; 2013 Aug; 26(8):1045-52. PubMed ID: 23736112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
    Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study.
    Zhang Y; Agnoletti D; Safar ME; Blacher J
    Hypertension; 2011 Aug; 58(2):155-60. PubMed ID: 21747047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.
    Ogihara T; Nakao K; Fukui T; Fukiyama K; Ueshima K; Oba K; Sato T; Saruta T;
    Hypertension; 2008 Feb; 51(2):393-8. PubMed ID: 18172059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension.
    Ohta Y; Kamide K; Hanada H; Morimoto S; Nakahashi T; Takiuchi S; Ishimitsu T; Tsuchihashi T; Soma M; Tomohiro Katsuya T; Sugimoto K; Rakugi H; Oukura T; Higaki J; Matsuura H; Shinagawa T; Miwa Y; Sasaguri T; Igase M; Miki T; Takeda K; Higashiura K; Shimamoto K; Katabuchi R; Ueno M; Hosomi N; Kato J; Komai N; Kojima S; Sase K; Iwashima Y; Yoshihara F; Horio T; Nakamura S; Nakahama H; Miyata T; Kawano Y
    Hypertens Res; 2020 Mar; 43(3):220-226. PubMed ID: 31748705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amlodipine + candesartan on cardiovascular events in hypertensive patients with coronary artery disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study).
    Yamaguchi J; Hagiwara N; Ogawa H; Koyanagi R; Kasanuki H; Takagi A; Mori F; Nagashima M; Yagi M;
    Am J Cardiol; 2010 Sep; 106(6):819-24. PubMed ID: 20816122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
    Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
    Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
    Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
    Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The X-cellent Study.
    Safar ME
    Am J Hypertens; 2006 Jan; 19(1):8-9. PubMed ID: 16461182
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
    Koh KK; Quon MJ; Han SH; Lee Y; Kim SJ; Koh Y; Shin EK
    Int J Cardiol; 2010 Apr; 140(1):73-81. PubMed ID: 19059660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis.
    Machura E; Szczepanska M; Ziora K; Ziora D; Swietochowska E; Barc-Czarnecka M; Kasperska-Zajac A
    Mediators Inflamm; 2013; 2013():760691. PubMed ID: 23476106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
    Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of candesartan and amlodipine on cardiovascular mortality and morbidity in Japanese high-risk hypertensive patients: rationale, design, and characteristics of candesartan antihypertensive survival evaluation in Japan extension (CASE-J Ex).
    Ueshima K; Oba K; Yasuno S; Fujimoto A; Sato T; Fukiyama K; Azuma J; Ogihara T; Saruta T; Nakao K;
    Contemp Clin Trials; 2009 Jan; 30(1):97-101. PubMed ID: 18824134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.